Literature DB >> 35859538

On the classification of impairment in neuropsychological research and practice in the neuro-oncological setting.

Kyle R Noll1, Jeffrey Wefel1.   

Abstract

Entities:  

Year:  2022        PMID： 35859538      PMCID： PMC9290879          DOI： 10.1093/nop/npac040

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN： 2054-2577


× No keyword cloud information.
  6 in total

1.  Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.

Authors:  Jacob J Mandel; David Cachia; Diane Liu; Charmaine Wilson; Ken Aldape; Greg Fuller; John F de Groot
Journal:  J Neurooncol       Date:  2016-06-07       Impact factor: 4.130

2.  International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

Authors:  Jeffrey S Wefel; Janette Vardy; Tim Ahles; Sanne B Schagen
Journal:  Lancet Oncol       Date:  2011-02-25       Impact factor: 41.316

3.  Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma.

Authors:  Derek R Johnson; Allison M Sawyer; Christina A Meyers; Brian Patrick O'Neill; Jeffrey S Wefel
Journal:  Neuro Oncol       Date:  2012-04-16       Impact factor: 12.300

4.  Depressive symptoms and executive function in relation to survival in patients with glioblastoma.

Authors:  Kyle R Noll; Catherine M Sullaway; Jeffrey S Wefel
Journal:  J Neurooncol       Date:  2019-01-24       Impact factor: 4.130

5.  Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe prior to surgical resection.

Authors:  Kyle R Noll; Catherine Sullaway; Mateo Ziu; Jeffrey S Weinberg; Jeffrey S Wefel
Journal:  Neuro Oncol       Date:  2014-09-16       Impact factor: 12.300

Review 6.  Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice.

Authors:  Ugonma N Chukwueke; Patrick Y Wen
Journal:  CNS Oncol       Date:  2019-02-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.